微流控市場－全球產業規模、佔有率、趨勢、機會和預測，依技術、材料、應用、地區和競爭格局分類，2020-2030年預測

2024年全球微流控市場規模為291億美元，預計2030年將以13.11%的複合年成長率成長至609.4億美元。微流控技術是指在微米級通道和腔室內精確操控微量流體，通常為奈升至皮升尺度。市場成長的主要驅動力是市場對小型化診斷平台的需求不斷成長，這些平台能夠實現快速且有效率的即時檢測。此外，生物醫學研究的進步，尤其是在需要高通量篩選和詳細細胞分析的領域，也顯著促進了市場擴張。

主要市場促進因素

主要市場挑戰

主要市場趨勢

目錄

第1章：產品概述

第2章：研究方法

第3章：執行概要

第4章：顧客之聲

第5章：全球微流控市場展望

• 市場規模及預測
  • 按價值
• 市佔率及預測
  • 依技術（醫療/保健、非醫療）分類
  • 依材料分類（矽、玻璃、聚合物、PDMS、其他）
  • 依最終用戶分類（晶片實驗室、晶片器官、連續流微流控、光流控和微流控、聲流控和微流控、電泳和微流控）
  • 按地區
  • 按公司（2024 年）
• 市場地圖

第6章：北美微流控市場展望

• 市場規模及預測
• 市佔率及預測
• 北美洲：國家分析
  • 美國
  • 加拿大
  • 墨西哥

第7章：歐洲微流控市場展望

• 市場規模及預測
• 市佔率及預測
• 歐洲：國家分析
  • 德國
  • 法國
  • 英國
  • 義大利
  • 西班牙

第8章：亞太微流控市場展望

• 市場規模及預測
• 市佔率及預測
• 亞太地區：國家分析
  • 中國
  • 印度
  • 日本
  • 韓國
  • 澳洲

第9章：中東與非洲微流控市場展望

• 市場規模及預測
• 市佔率及預測
• 中東和非洲：國家分析
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 南非

第10章：南美洲微流控市場展望

• 市場規模及預測
• 市佔率及預測
• 南美洲：國家分析
  • 巴西
  • 哥倫比亞
  • 阿根廷

第11章：市場動態

• 促進要素
• 挑戰

第12章：市場趨勢與發展

• 併購（如有）
• 產品發布（如有）
• 最新進展

第13章：全球微流控市場：SWOT分析

第14章：波特五力分析

• 產業競爭
• 新進入者的潛力
• 供應商議價能力
• 顧客的力量
• 替代產品的威脅

第15章：競爭格局

• UFluidix
• Bio-Rad Laboratories Inc.
• Emulate Inc.
• Dolomite Microfluidics (Blacktrace Holdings Ltd)
• Sphere Fluidics Limited
• FluIdigm Corporation
• Illumina Inc.
• Micronit Microfluidics
• PerkinElmer Inc.
• Hesperos Inc.

第16章：策略建議

第17章調查會社について,免責事項

The Global Microfluidics Market, valued at USD 29.10 Billion in 2024, is projected to experience a CAGR of 13.11% to reach USD 60.94 Billion by 2030. Microfluidics involves the precise manipulation of minute fluid volumes, typically at the nanoliter to picoliter scale, within micro-scale channels and chambers. The market's growth is primarily driven by the increasing demand for miniaturized diagnostic platforms, enabling rapid and efficient point-of-care testing. Additionally, advancements in biomedical research, particularly in areas requiring high-throughput screening and detailed cellular analysis, significantly contribute to market expansion.

Key Market Drivers

The growing demand for point-of-care diagnostics significantly propels the microfluidics market by addressing the need for rapid, decentralized, and accessible testing solutions. This driver is particularly relevant in managing chronic diseases and infectious outbreaks, where timely, on-site results improve patient outcomes and healthcare efficiency. Microfluidic technologies enable miniaturization and integration of complex diagnostic assays onto portable devices, allowing testing closer to the patient, even in resource-limited settings. The clear preference for these convenient methods is evident; according to OUCRU, in September 2024, a study published in Open Forum Infectious Diseases found that 96.5% of customers supported the future introduction of C-reactive protein point-of-care testing at pharmacies. This strong end-user endorsement underscores demand-side influence on innovation and adoption within the microfluidics sector.

Key Market Challenges

The complexity and high cost associated with microfluidic device fabrication represent a significant impediment to the widespread expansion of the Global Microfluidics Market. Manufacturing these intricate devices requires specialized processes, precision engineering, and often unique materials, which collectively elevate production expenses. This directly translates into higher unit costs for microfluidic products, making them less accessible for a broader range of applications and deterring potential commercial adoption across various industries.

Key Market Trends

Artificial Intelligence and Data Analytics Integration in Microfluidic Systems is a significant trend transforming the microfluidics market by enhancing the capabilities of device design, operation, and data interpretation. This integration allows for sophisticated analysis of complex biological data generated from microfluidic experiments, leading to improved accuracy and efficiency in various applications. According to Founders Forum Group, as of 2025, over 73% of organizations worldwide are either using or piloting AI in core functions, indicating a broad industry shift towards intelligent systems. This widespread adoption facilitates the development of self-optimizing microfluidic platforms, accelerating research cycles and reducing human intervention. For example, Microsoft announced in September 2025 that it had successfully developed an in-chip microfluidic cooling system that leverages AI to identify unique heat signatures on a chip and direct coolant with more precision, enhancing heat removal by up to three times compared to traditional cold plates. This demonstrates AI's direct impact on optimizing the physical performance and sustainability of microfluidic components.

Key Market Players

• UFluidix
• Bio-Rad Laboratories Inc.
• Emulate Inc.
• Dolomite Microfluidics (Blacktrace Holdings Ltd)
• Sphere Fluidics Limited
• FluIdigm Corporation
• Illumina Inc.
• Micronit Microfluidics
• PerkinElmer Inc.
• Hesperos Inc.

Report Scope:

In this report, the Global Microfluidics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Microfluidics Market, By Technology:

• Medical/Healthcare
• Non-medical

Microfluidics Market, By Material:

• Silicon
• Glass
• Polymer
• PDMS
• Others

Microfluidics Market, By End User:

• Lab-on-a-chip
• Organs-on-chips
• Continuous flow microfluidics
• Optofluidics and microfluidics
• Acoustofluidics and microfluidics
• Electrophoresis and microfluidics

Microfluidics Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Microfluidics Market.

Available Customizations:

Global Microfluidics Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Microfluidics Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Technology (Medical/Healthcare, Non-medical)
  • 5.2.2. By Material (Silicon, Glass, Polymer, PDMS, Others)
  • 5.2.3. By End User (Lab-on-a-chip, Organs-on-chips, Continuous flow microfluidics, Optofluidics and microfluidics, Acoustofluidics and microfluidics, Electrophoresis and microfluidics)
  • 5.2.4. By Region
  • 5.2.5. By Company (2024)
• 5.3. Market Map

6. North America Microfluidics Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Technology
  • 6.2.2. By Material
  • 6.2.3. By End User
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Microfluidics Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Technology
      • 6.3.1.2.2. By Material
      • 6.3.1.2.3. By End User
  • 6.3.2. Canada Microfluidics Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Technology
      • 6.3.2.2.2. By Material
      • 6.3.2.2.3. By End User
  • 6.3.3. Mexico Microfluidics Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Technology
      • 6.3.3.2.2. By Material
      • 6.3.3.2.3. By End User

7. Europe Microfluidics Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Technology
  • 7.2.2. By Material
  • 7.2.3. By End User
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Microfluidics Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Technology
      • 7.3.1.2.2. By Material
      • 7.3.1.2.3. By End User
  • 7.3.2. France Microfluidics Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Technology
      • 7.3.2.2.2. By Material
      • 7.3.2.2.3. By End User
  • 7.3.3. United Kingdom Microfluidics Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Technology
      • 7.3.3.2.2. By Material
      • 7.3.3.2.3. By End User
  • 7.3.4. Italy Microfluidics Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Technology
      • 7.3.4.2.2. By Material
      • 7.3.4.2.3. By End User
  • 7.3.5. Spain Microfluidics Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Technology
      • 7.3.5.2.2. By Material
      • 7.3.5.2.3. By End User

8. Asia Pacific Microfluidics Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Technology
  • 8.2.2. By Material
  • 8.2.3. By End User
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Microfluidics Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Technology
      • 8.3.1.2.2. By Material
      • 8.3.1.2.3. By End User
  • 8.3.2. India Microfluidics Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Technology
      • 8.3.2.2.2. By Material
      • 8.3.2.2.3. By End User
  • 8.3.3. Japan Microfluidics Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Technology
      • 8.3.3.2.2. By Material
      • 8.3.3.2.3. By End User
  • 8.3.4. South Korea Microfluidics Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Technology
      • 8.3.4.2.2. By Material
      • 8.3.4.2.3. By End User
  • 8.3.5. Australia Microfluidics Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Technology
      • 8.3.5.2.2. By Material
      • 8.3.5.2.3. By End User

9. Middle East & Africa Microfluidics Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Technology
  • 9.2.2. By Material
  • 9.2.3. By End User
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Microfluidics Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Technology
      • 9.3.1.2.2. By Material
      • 9.3.1.2.3. By End User
  • 9.3.2. UAE Microfluidics Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Technology
      • 9.3.2.2.2. By Material
      • 9.3.2.2.3. By End User
  • 9.3.3. South Africa Microfluidics Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Technology
      • 9.3.3.2.2. By Material
      • 9.3.3.2.3. By End User

10. South America Microfluidics Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Technology
  • 10.2.2. By Material
  • 10.2.3. By End User
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Microfluidics Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Technology
      • 10.3.1.2.2. By Material
      • 10.3.1.2.3. By End User
  • 10.3.2. Colombia Microfluidics Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Technology
      • 10.3.2.2.2. By Material
      • 10.3.2.2.3. By End User
  • 10.3.3. Argentina Microfluidics Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Technology
      • 10.3.3.2.2. By Material
      • 10.3.3.2.3. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Microfluidics Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. UFluidix
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Bio-Rad Laboratories Inc.
• 15.3. Emulate Inc.
• 15.4. Dolomite Microfluidics (Blacktrace Holdings Ltd)
• 15.5. Sphere Fluidics Limited
• 15.6. FluIdigm Corporation
• 15.7. Illumina Inc.
• 15.8. Micronit Microfluidics
• 15.9. PerkinElmer Inc.
• 15.10. Hesperos Inc.

16. Strategic Recommendations

17. About Us & Disclaimer